Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | APAF1 | O14727 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28113890 | 0.98 | SLC22A6 (0.67) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL20481507 | 0.89 | SLC22A6 (0.55) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL148210 | 0.89 | SLC22A6 (0.67) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL28215558 | 0.88 | SLC22A6 (0.65) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL17536618 | 0.88 | SLC22A6 (0.65) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL28021733 | 0.88 | SLC22A6 (0.65) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL6835665 | 0.87 | SLC22A6 (0.68) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL1714417 | 0.87 | SLC22A6 (0.68) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL3446433 | 0.85 | SLC22A6 (0.66) | SLC22A6PKMPBRM1MAPTKDM4E | |
| SCHEMBL10599504 | 0.85 | SLC22A6 (0.61) | SLC22A6PKMPBRM1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12633376-B2 | System and method for risk assessment of autism spectrum disorder | TATA CONSULTANCY SERVICES LIMITED (IN) | 2026-05-19 | — | — | US | claimed |
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | UNIV IOWA RES FOUND (US) | 2026-02-26 | — | — | US | claimed |
| US-20250367246-A1 | IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES | SOLAREA BIO INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250356948-A1 | SYSTEM AND METHOD FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER | TATA CONSULTANCY SERVICES LIMITED (IN) | 2025-11-20 | — | — | US | claimed |
| US-12440523-B2 | Immunomodulatory compositions comprising microbial entities | SOLAREA BIO, INC. (US) | 2025-10-14 | — | — | US | claimed |
| CN-119951426-A | Double-network gel microsphere with pH response and preparation method and application thereof | 合肥工业大学 | 2025-05-09 | — | — | CN | claimed |
| CN-118931933-A | Recombinant vector for biosynthesis of indopropionic acid, engineering bacterium and application thereof | 镇江市天益生物科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| EP-4452287-A2 | IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES | Solarea Bio, Inc. (US) | 2024-10-30 | — | — | EP | claimed |
| CN-118831071-A | Sequential multistage targeted delivery system for repairing intestinal barrier and preparation method thereof | 大连理工大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118696825-A | Liaodong clove immature embryo regeneration method | 青海省农林科学院 | 2024-09-27 | — | — | CN | claimed |
| US-20050197253-A1 | Methods for improving growth and crop productivity of plants by adjusting plant hormone levels, ratios and/or co-factors | BANK OF AMERICA, NA | 2005-09-08 | — | — | US | claimed |
| WO-2005021715-A2 | METHODS FOR IMPROVING GROWTH AND CROP PRODUCTIVITY OF PLANTS BY ADJUSTING PLANT HORMONE LEVELS, RATIOS AND/OR CO-FACTORS | STOLLER ENTERPRISES, INC. (US) | 2005-03-10 | — | — | WO | claimed |
| WO-2005018319-A2 | SUPPRESSING PLANT PATHOGENS AND PESTS WITH APPLIED OR INDUCED AUXINS | STOLLER ENTERPRISES, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| US-20050043177-A1 | Controlling plant pathogens and pests with applied or induced auxins | BANK OF AMERICA, NA | 2005-02-24 | — | — | US | claimed |
| EP-1372571-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | New Century Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | NEW CENTURY PHARMACEUTICALS, INC. | 2002-12-19 | — | — | US | claimed |
| WO-2002074246-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1171603-A1 | A PROCESS FOR PRODUCING PURIFIED BIOLOGICALLY ACTIVE, FREE FORM OF RECOMBINANT HUMAN INTERFERON GAMMA | Vyas, Sharad Kumar (IN) | 2002-01-16 | — | — | EP | claimed |
| WO-2001057218-A1 | A PROCESS FOR PRODUCING PURIFIED BIOLOGICALLY ACTIVE, FREE FORM OF RECOMBINANT HUMAN INTERFERON GAMMA | VYAS SHARAD KUMAR (IN) | 2001-08-09 | — | — | WO | claimed |
| EP-0175577-A2 | Microchemiluminescent assay system | Kiel, Jonathan L (US) | 1986-03-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12633376-B2 | System and method for risk assessment of autism spectrum disorder | TPH1, KYNU, TPH2 | SLC22A6 1288/4885PKM 674/4885PBRM1 1388/4885 |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | ALB, TYMP, SHBG | SLC22A6 588/4885PKM 4433/4885PBRM1 4366/4885 |
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | KYNU, AADAT, TPH1 | SLC22A6 891/4885PKM 1234/4885PBRM1 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.